Expertise: Clinical Trials
Imorphics has developed a suite of software which provides quantitative versions of the Rheumatoid Arthritis MRI Scoring system (RAMRIS).
Fully automated tools have been produced for the sub-components of the RAMRIS measures – synovitis, erosion, oedema and joint space width. Early studies have shown that this method offers improved sensitivity over the semi-quantitative RAMRIS. Phase III trials using our approach are complete, and results will be published soon. The use of Imorphics models promises to improve sensitivity leading to smaller, shorter trials, and better discrimination between drugs which are already approved for use.